Perimeter Medical Imaging AI Announces Second Quarter 2025 Financial Results

Core Insights - Perimeter Medical Imaging AI, Inc. reported strong financial results for Q2 2025, with revenues of approximately $506,000, representing a 105% increase compared to Q2 2024 [5][8] - The company is advancing its next-generation Perimeter B-Series device, which combines AI technology with OCT, and has shown promising results in clinical trials [5][14] - Perimeter continues to expand its market presence, with significant adoption of its Perimeter S-Series device and partnerships for future studies [5][4] Financial Performance - Q2 2025 revenue was approximately $506,000, up 105% from Q2 2024, with a gross margin of 70% [8] - Operating expenses for Q2 2025 were approximately $4.3 million, a 22% reduction from $5.5 million in Q2 2024, with expectations of a further 30% reduction starting in Q3 2025 [9] - The net loss for Q2 2025 was approximately $3.9 million, or $0.04 per share, compared to a net loss of $3.2 million, or $0.05 per share, in Q2 2024 [10] Product Development and Market Expansion - The Perimeter S-Series device has been utilized to image over 3,000 patients, with a 93% year-over-year increase in case volumes for Q2 2025 [5] - The company announced the launch of the OCT-Tissue Surveillance Registry to collect data for future product development [5] - Perimeter has entered into a Development Support Agreement with Intermountain Health to evaluate the potential value of its OCT technology [5] Capital Raising and Financial Position - Perimeter closed an offering of units, raising approximately $2.2 million in June 2025 and an additional $1.6 million in July 2025, totaling 17,849,468 units issued [4][6] - As of June 30, 2025, the company had approximately $1.4 million in cash, not including additional proceeds from the recent offering [11]